Annual Meeting Travel Awards

Each year the ANA selects the top-ranked abstracts submitted by fellows, residents, and early-career faculty to receive a travel award to attend the Annual Meeting and present their work.The amount of the travel award is based on the number of miles the recipient lives from the location of the Annual Meeting. 

2018 Travel Awardees

Ogata Hidenori, MD, PhD, Kyushu University | S101 A Combined Immunogenetic and Cerebrospinal Fluid Cytokine Study in Anti-neurofascin155 Antibody-positive Neuropathy

Gregory Day, MD, MSc, Washington University in St. Louis | S102 Quantifying Biomarkers of Neuronal Injury, Neuroinflammation and Neurotransmission in AntibodyMediated Encephalitis

Amanda Piquet, MD, University of Colorado | S103 Clinical Features of Glycine Receptor Antibody Syndrome: A Series of Eleven Cases

Lauren Reoma, MD, National Institute of Neurological Disorders and Stroke (NINDS) | S104 Reversal of Immune Exhaustion Against HIV in Two Patients Following Anti-PD1 Therapy

Salman Farooq, MBBS, Aga Khan University | S124 Frequency and Impact of Cerebral Infarctions in Patients with Tuberculous Meningitis

Kristin Guilliams, MD, MSCI, Washington University in St. Louis | S125 Cerebral Oxygen Metabolism within the Watershed Region is Age-dependent Reflecting Peak Metabolic Demand and Increased Stroke Risk in Young Children

Jason Hinman, MD, PhD, University of California, Los Angeles | S126 Subcortical Stroke Primes Tau Phosphorylation and Impairs Dendritic Complexity in Cortical Neurons Through Up-regulation of the Microtubule Affinity-regulating Kinase, Mark4

Aaron Matthews, BSN, MSN, University of Virginia | S127 iTREAT: Novel Telestroke Application with Rural EMS Providers

Mellanie Springer, MD, MSc, Albert Einstein College of Medicine S128 Racial Disparities in Hospital Arrival After Stroke

Syed Ali Raza, MD, Louisiana State University Shreveport | S130 Temporal Profiles of Kv1.3 Channel Expression By Microglia Following Transient Middle Cerebral Artery Occlusion

Thomas Wingo, MD, Atlanta VA Medical Center | S151 Quantitative Proteomics of the Human Brain Reveals Proteins Associated with Cognitive Resilience

Michelle Caunca, BSc, University of Miami Miller School of Medicine | S153 Greater Body Mass Index is Associated with Smaller Cortical Thickness in the Alzheimer Disease-Signature Regions: The Northern Manhattan Study

Erik Musiek, MD, PhD, Washington University in St. Louis | S154 Circadian Clock Disruption Differentially Regulates Amyloid-beta and Tau Pathology in Mouse Models of Alzheimer Disease

Rabab Al-Lahham, PhD, The University of Texas Medical Branch | S155 Immunotherapy Targeting Tau Oligomeric Strains in Aged Transgenic Animals of Tauopathy

Lingyan Ping, PhD, Emory University | S158 Quantitative Proteomics of CSF and Plasma Reveals Candidate Biomarkers Linked to Immune-related Pathways in Alzheimer’s Disease

Measho Abreha, PhD, Emory University | S159 Comprehensive Mapping of Alzheimer’s Disease Brain Ubiquitin Pattern Revealed Novel Tau Ubiquitylation Sites

Defne Amado, MD, PhD, University of Pennsylvania | S161 AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes TCell-Mediated Hippocampal Degeneration

Luis Paixao, MD, MSc, Massachusetts General Hospital and Harvard Medical School | S163 EEG-Based Brain Age and Its Relation with Mortality 

Barbara Stopschinski, MD, University of Texas Southwestern Medical Center | S165 Specific Glycosaminoglycan Chain Length and Sulfation Patterns Are Required for Cell Uptake of Tau vs. α-synuclein and β-amyloid Aggregates

Wyatt Bensken, BS, National Institute of Neurological Disorders and Stroke (NINDS) | S176 The Research Enterprise: Understanding Neurologist’s Contributions to Science and the Pathway to Becoming a Successful Physician-Scientist

Ushtar Amin, MD, University of South Florida | S182 Association Between POSTS and Lambda Waves on EEG

Raquel Valdes Angues, PhD, MScGH, Oregon Health & Science University | S192 Real-time Medical Cartography of Nodding Syndrome Built by Village-based Lay Health Reporters

Amir Abdallah, MD, Mbarara University of Science and Technology | S194 Validation of the Intracerebral Hemorrhage Score in Uganda: A Prospective Cohort Study

Adys Mendizabal, MD, MA, Hospital of the University of Pennsylvania | S203 Comorbid Disease Drives Short Term Hospitalization Outcomes in Multiple Sclerosis Patients  

Kelly Harper, BPS, Vanderbilt University | S204 Patient Satisfaction with a Teleneurology Service Provided via Tablet Technology

Nicole Rosendale, MD, University of California, San Francisco | S205 Inpatient Neurologic Care of Homeless Individuals

Camden MacDowell, MD, Princeton University | S208 Towards Adaptive Neural-prosthetics: Using Closed-loop Machine Learning Algorithms and Multi-site Electrical Microstimulation to Produce Specific Neural Firing Patterns

Abby Olsen, MD, PhD, Partners Neurology | S211 Defining the Contribution of Glia to Alphasynucleinopathies

Taylor Floyd, BS, Weill Cornell Medicine | S213 A Mouse Model of Human Recessive Cerebellar Ataxia: Point Mutation in Small Nuclear RNA, Rnu12

Matthew Barrett, MD, MSc, University of Virginia | S214 Cholinergic Nucleus 4 Density and Cognition in Parkinson Disease

Michelle Fullard, MD, MS, University of Pennsylvania | S215 State-level Prevalence, Utilization and Cost Varies Widely Among Medicare Beneficiaries with Parkinson’s Disease

Taiki Yabumoto, MD, Osaka University | S217 Establishment of Slowly Progressive Parkinson’s Disease Marmoset Model by á-synuclein Fibril Injection

Mikayla Roof, Vanderbilt University | S218 Effects of BDNF rs6265 Genotype and Exercise on Quality of Life in Patients with Parkinson's Disease   

Angela Deutschlander, MD, Mayo Clinic Florida | S219 Genetic Risk Variants for Parkinson's Disease (PD) and for Cognitive Impairment and Their Influence on Clinical Features in PD

Baijayanta Maiti, MD, PhD, Washington University in St. Louis | S221 Cerebellar Resting-State Functional Connectivity in Parkinson Disease-The Spotlight Veers to the Vermis

David Coughlin, MD, University of Pennsylvania | S222 Regional [18F]-AV1451 Uptake in DLB

Philip Lee, BS, Medical University of South Carolina | S226 Executive Function Differences Between Pharmacologic Sub-types of Parkinson’s Freezing of Gait

Brian Trummer, MD, PhD, National Institute of Neurological Disorders and Stroke (NINDS) | S229 Cross-sectional Validation Study of the Spastic Paraplegia Rating Scale (SPRS) and SF-36 Health Questionnaire in Hereditary Spastic Paraplegia

Pavan Bhargava, MD, Johns Hopkins University | S249 Bile Acid Metabolism is Altered in Multiple Sclerosis

Francesca Cignarella, PhD, Washington University in St Louis | S250 Immunomodulatory Role of Adiponectin in Experimental Models of Multiple Sclerosis

Karla Gray-Roncal, MS, Johns Hopkins University | S251 US-based African Americans with Multiple Sclerosis Have Greater Disability and Lower Socio-economic Status Than Caucasian Americans

Yuri Nakamura, MD, PhD, Kyushu University | S252 A Comparison of Brain MRI Features Between Asian and Caucasian Patients with Multiple Sclerosis

John Ciotti, MD, Washington University in St. Louis | S253 Validation of Algorithm to Retrospectively Capture the Expanded Disability Status Scale in Patients with Multiple Sclerosis

Sudeep Rajpoot, MD, American University of Antigua | S261 Hyperammonemia Encephalopathy: A Rare Cause in a Healthy Child

Stefanie Geisler, MD, Washington University in St. Louis | S268 SARM1 Dominant-Negative-A New Therapeutic Approach to the Treatment of Axonal Degeneration

Jamal Mohamud, BS, Michigan State University | S295 The Proteasome: Targeting the NF-κB pathway in the Treatment of Glioblastoma Multiforme

Dana Almedallah, MBBs, Imam Abdulrahman Bin Faisal University | S296 Implementing Apparent Diffusion Coefficient Values to Distinguish Types of Pediatric Brain Tumor: A Possible Approach  

Scott DeBoer, MD, PhD, Johns Hopkins University | S301 Cerebrolysin After Stroke Leads to Spontaneous Motor Recovery in the Absence of Reduced Stroke Volume in a Mouse Model of Stroke  

Nigel Pedersen, MD, Emory University | S306 The Supramammillary Node of the Ascending Arousal System-Afferent and Efferent Connections

Alice Bittar, PhD, The University of Texas Medical Branch | S311 Characterization, Toxicity and Propagation of TBI Brainderived Soluble Tau Strains

Maria Pia Giannoccaro, MD, University of Oxford M101 Passive Transfer of Human CASPR2 Antibodies Into Mice Causes Behavioral and Neuropathological Changes

Sebastian Lopez-Chiriboga, MD, Mayo Clinic | M102 LGI1 and CASPR2 Autoimmunity Phenotype and Outcome in Pediatric Patients

Sophie Duong, Yale School of Medicine | M103 Neurotoxicities Associated with Immune Checkpoint Inhibitor Therapy

Sara Dehbashi, MD, The University of Texas Medical Branch | M104 Co-occurrence of Multiple Sclerosis and Myasthenia Gravis

Neel Fotedar, MD, University Hospitals Cleveland Medical Center | M105 A Novel Autoimmune Encephalitis-Neuromyelitis Optica Spectrum Disorder Overlap Syndrome

Aradhana Sahoo, BS, Mayo Clinic | M117 TDP-43 Associated Hippocampal Atrophy Evaluated with FreeSurfer Subfield Analysis

Yukako Kawasaki, MD, Johns Hopkins University | M118 Head Circumference and Brain Volume

Alexander Merkler, MD, Weill Cornell Medicine | M122 Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction

Amir Shaban, MD, University of Iowa | M123 Novel Score to Predict Outcomes in Patients with Cerebral Venous Sinus Thrombosis

Sidhant Varma, MS, Medical College of Wisconsin | M124 Identifying Neural Correlates of Speech Articulation Speed in Chronic Stroke Patients

Alison Cloutier, MS, Massachusetts General Hospital | M125 Clinical Translation of Early Clinical and Neuroimaging Biomarkers to Predict Stroke Motor Recovery

Vahid Eslami, MD, University of Texas Health Science Center | M126 An Overview of the Characteristics of Ischemic Stroke Clinical Trials in The Last Decade

Laura Stein, MD, Icahn School of Medicine at Mount Sinai | M127 Readmission to Another Hospital Following Acute Stroke Admission is Associated With Worse Outcomes: Nationally Representative Data

Roland Faigle, MD, PhD, Johns Hopkins University | M128 Racial and Ethnic Differences in Dysphagia Severity and Feeding Tube Placement After Intracerebral Hemorrhage

Mohammed Badi, MD, Mayo Clinic Florida | M129 Total Cerebral Small Vessel Disease Score and All-cause Mortality in the Mayo Clinic Florida Familial Cerebrovascular Disease Registry

Jacqueline Palmer, DPT, PhD, Emory University | M130 Interhemispheric Connectivity Between Lower Limb Motor Regions in Stroke Survivors

Nicolas Barthélemy, PhD, Washington University in St. Louis | M150 Profiling Alzheimer Disease Stages in Dominantly Inherited Alzheimer Disease Using CSF Tau Phosphorylation Isoforms: Position Matters

Christopher Brown, PhD, University of Kentucky | M152 Cerebrovascular and Alzheimer's Pathology Preferentially Affect White Matter Pathways Within Large Scale Brain Networks Compared to Pathways Between Networks

Chadwick Hales, MD, PhD, Emory University | M153 Proteomic Changes in Frontotemporal Lobar Degeneration Due to Microtubule Associated Protein Tau (MAPT) Mutations

Urmi Sengupta, MS, The University of Texas Medical Branch | M155 The Role of α-Synuclein Strains on Tau Aggregation in Disease Pathology

Rafi Haque, BSE, Emory University | M156 A Passive Assessment of Discrimination Memory During Healthy Aging, Mild Cognitive Impairment, and Alzheimer's Disease

Keenan Walker, PhD, Johns Hopkins University | M157 Systemic Inflammation During Midlife and Cognitive Change Over 20 Years: The ARIC Study

Eric Dammer, PhD, Emory University | M159 Effects of APOE Genotype on Protein Co-expression in Alzheimer’s Disease

Alex Nackenoff, PhD, Vanderbilt University | M160 PLD3 Alzheimer's Risk Gene Functional Analysis

Yuka Miyamoto, MD, Kochi Medical School | M162 Clinical and Neuropathological Features of Seven Cases of Neuronal Intranuclear Inclusion Disease (NIID)

Carolin Koriath, MD, University College London | M163 Predictors for a Dementia Gene Mutation Based on Gene-Panel Next-Generation Sequencing of a Large Dementia Referral Series

Nicholas Seyfried, PhD, Emory University | M164 Establishing a Roadmap for Brain-based Protein Biomarkers in Alzheimer’s Disease

Ahmed Bahrani, MS, University of Kentucky | M165 Semi-Automated Volumetric Quantifying Method of Cerebral Microhemorrhage Using T2*-Weighted MRI Images

Rebecca DiBiase, BA, Johns Hopkins University | M166 The Effects of Gravidity and Parity on Risk of Cognitive Impairment and Amyloid Plaque Deposition

Mohammad Tabaeizadeh Fesharaki, MD, Massachusetts General Hospital | M180 Levosimendan Exerts Anticonvulsant Properties Against PTZ-induced Seizures in Mice Through Activation of nNOS/ NO Pathway: Role for KAPT Channel

Churl-Su Kwon, MD, MPH, Icahn School of Medicine at Mount Sinai | M182 Readmission After an Epilepsy Surgical Intervention-a Nationwide Cohort Analysis

Vaibhav Goswami, MD, New York Medical College | M183 Na Channel Agents are Not Interchangeable: Precision Epilepsy Therapy Using Quinidine vs. Phenytoin in KCNT1 Associated Migrating Partial Seizures of Infancy

Scott Woolf, DO, Westchester Medical Center | M184 Occipital Seizures Related to Non-ketotic Hyperglycemia (NKH) 

Bridgette Jeanne Billioux, MD, National Institute of Neurological Disorders and Stroke (NINDS) | M191 Case Series of Ebola Survivors from Liberia with Neurological Sequelae Undergoing In-Depth Neurological Evaluation at the National Institutes of Health

Furqan Waseem, MD, SUNY Upstate Medical University | M195 Post-Malaria Neurological Syndrome

Altaf Saadi, MD, University of California, Los Angeles | M204 Mistrust of Researchers, Not Physicians, Predicts Stroke Knowledge: Analysis of a Randomized Behavioral Intervention Trial Among Black, Latino, Korea, and Chinese Americans

Sneha Mantri, MD, MS, University of Pennsylvania | M205 Ethnic and Geographic Disparities and Frank Prescribing Errors in Parkinson Disease

Jordan Clay, MD, University of Kentucky | M206 Alert Protocol Reduces Time to Administration of Second-line Antiseizure Medications for Status Epilepticus

Mohammad Shahnawaz, PhD, University of Texas Medical School at Houston | M213 A Highly Sensitive and Specific Biochemical Test for the Diagnosis of Parkinson’s Disease Based on Detection of  AlphaSynuclein Oligomers in Cerebrospinal Fluid Sinem

Balta Beylergil, MD, Case Western Reserve University | M215 Predicting Prevalence and Irregularity of Dystonic Tremor Using Machine Learning

Suman Dutta, PhD, University of California, Los Angeles | M216 α-synuclein in Brain-derived Blood Exosomes Distinguishes Multiple System Atrophy From Parkinson’s Disease

K. Cannard, Vanderbilt University | M218 Feasibility of Recruitment in Clinical Trials Investigating Deep Brain Stimulation as a Treatment in Early-Stage Parkinson’s Disease

Krisna Maddy, BA, University of Pennsylvania | M219 Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease

Richa Tripathi, MD, Emory University | M221 Deep Brain Stimulation in Parkinson: Use of Kinematics to Study Impact of DBS on Gait

Albert Davis, MD, PhD, Washington University in St. Louis | M222 Regulation of alpha-synuclein Pathology by Apolipoprotein E

Mallory Hacker, PhD, Vanderbilt University | M225 Asymmetric Effects of Bilateral Deep Brain Stimulation on Underlying Motor Symptoms in Early Stage Parkinson’s Disease

Tuhin Virmani, MD, PhD, University of Arkansas | M226 Differential Gait Progression in Idiopathic Parkinson’s Disease with and without Freezing of Gait

Allison Bay, MPH, Emory School of Medicine/Atlanta VA Hospital | M227 The Association Between Parkinson’s Disease Symptom Side-of-Onset, Performance on the Unified Parkinson’s Disease Rating Scale Part IV: Motor Complications, and Environmental Exposures

Tritia Yamasaki, MD, PhD, University of Kentucky | M229 Distinct Biochemical and Morphological Characteristics of Proteopathic alpha-Synuclein Derived from Parkinson’s Disease and Multiple System Atrophy Brain are Maintained on in vitro Passage

Ryan Schubert, MD, University of California, San Francisco | M251 Using Comprehensive Phage Display Coupled With Next-generation Sequencing to Define the Evolution of Autoantibodies and Viral Antibodies in the Two Years After a First Demyelinating Event

Bailey Loving, BS, University of Colorado, Denver | M252 The Role of Microglial Lipoprotein Lipase in Remyelination

Xiaoming Jia, MD, MEng, University of California, San Francisco | M253 Interrogation of Exonic Variants in Secondary Progressive Multiple Sclerosis Uncovers Mutations in Genes for Hereditary Spastic Paraplegias

Yi Li, Weill Cornell Medicine-Qatar | M254 Corneal Confocal Microscopy: An Ophthalmologic Endpoint for Inflammatory Cells in Patients with Multiple Sclerosis

Peter Forgacs, MD, Weill Cornell Medicine | M261 Characterization of Network Connectivity in EEG Recordings: Applications to Post-cardiac Arrest Coma

Payam Mohassel, MD, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) | M268 Dysregulation of the TGF-beta Pathway in Collagen VI-related Muscular Dystrophy Predisposes Myofibers to Injury and Interferes With Muscle Regeneration

Jeffrey Ehmsen, MD, PhD, MPH, Johns Hopkins University | M269 Searching for Targets to Modify the Trajectory of Neurogenic Skeletal Muscle Atrophy

Brett Morrison, MD, PhD, Johns Hopkins University | M271 Focal Reduction of Monocarboxylate Transporter 1 (MCT1) in Macrophages Delays Peripheral Nerve Regeneration

Gary Zirpoli, PhD, Massachusetts General Hospital and Harvard Medical School | M273 Anthropometric, Lifestyle and Hormonal Risk Factors for Peripheral Neuropathy in the Nurses’ Health Study-II

Marie Wencel, BS, University of California, Irvine | M274 Feasibility and Validation of Modified Oculobulbar Facial Respiratory Score (mOBFRS) in Sporadic Inclusion Body Myositis

Yolanda Pina, MD, University of South Florida | M295 Personalized Medicine Diagnosis and Response to Treatment with Braf Mek Inhibition in a Pleomorphic Xanthoastrocytoma Patient

Havva Keskin, PhD, Emory University | M296 Understanding The Role of GabaA Receptors in Medulloblastoma as a Therapeutic Target

Milan Chheda, MD, Washington University in St. Louis | M298 Developing Zika Virus as a New Treatment for Glioblastoma

Asher Albertson, MD, PhD, Washington University in St. Louis | M302 Axonal Sprouting of Thalamocortical Neurons is Essential for Recovery After Thalamic Injury
Jon Willie, MD, PhD, Emory University | M305 Direct Electrical Stimulation of the Lateral Hypothalamic Area Consolidates Wake and Ameliorates Cataplexy in a Mouse Model of Narcolepsy
Type 1

Jagan Pillai, MBBS, PhD, Cleveland Clinic | M306 Alteration of Unique Neuroinflammatory Mediators Relative to Sleep Dysfunction in Alzheimer’s Disease with Mild Cognitive Impairment

Emily Hokett, BA, Georgia Institute of Technology | M307 Age-Related Changes in Sleep Quality, Associative Memory, and Oscillatory Power

Andrea Schneider, MD, PhD, Johns Hopkins University | M311 Head Injury and Long-Term Risk of Cognitive Decline and Dementia: the Atherosclerosis Risk in Communities (ARIC) Study   
 

Back to Awards